798 results on '"Antibodies -- Health aspects -- Research"'
Search Results
302. Investigators from University of Minnesota Zero in on COVID-19 (Identification of Natural Sars-cov-2 Infection In Seroprevalence Studies Among Vaccinated Populations)
303. Study identifies how Epstein-Barr virus triggers multiple sclerosis
304. How the COVID Virus Sneaks Past Immune Defenses
305. Study: Omicron antibodies may block Delta variant infection
306. United Kingdom : Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in studies from Oxford and Washington Universities
307. SARS-COV-2 GOES 'UNDERGROUND' TO SPREAD FROM CELL TO CELL
308. Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization
309. Id21covid005 - Covid-19 Emergency. Supply Of Systems For The Qualitative Research Of Antigens And Antibodies Of The Sars-cov-2 Virus
310. Brii Bio Announces Amubarvimab/Romlusevimab Combination Received Approval from NMPA as First COVID-19 Neutralizing Antibody Combination Therapy in China
311. NATURAL COVID-19 INFECTIONS PROTECT AGAINST SARS-COV-2, GAMMA AND DELTA VARIANTS
312. Natural COVID-19 infections protect against SARS-COV-2, gamma and delta variants
313. Validation Study Showcases Success of LSBD's Rapid SARS-CoV-2 Antibody Test
314. Validation Study Showcases Success of LSBD's Rapid SARS-CoV-2 Antibody Test
315. Those who survived COVID-19 and then got vaccinated have more durable antibodies, study finds
316. ANOTHER VEIN OF TREATMENT; COVID SURVIVORS' BLOOD PLASMA CAN HELP AGAINST VIRUS
317. Covid antibodies 'last for at least six months after infection for most people'; Experts from UK Biobank, a major biomedical database and research resource, have found that antibodies produced by infection may provide a degree of protection for at least half a year
318. Coronavirus immunity 'could last just 5 months and people can still pass it on'; A Public Health England study identified 44 possible cases of reinfection, while experts warned it is likely those who have recovered from coronavirus could still carry the disease and pass it to others
319. Different patterns of peripheral migration by memory [CD4.sup.+] and [CD8.sup.+] T cells
320. Studies from Department of Anesthesiology and Reanimation in the Area of COVID-19 Described (Cardiac Surgery With Cardiopulmonary Bypass Markedly Lowers Sars-cov-2 Antibody Titer)
321. Investigators at St. Jude Children's Research Hospital Report Findings in COVID-19 [Host Predictors of Broadly Cross-reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2) Variants of Concern Differ Between ...]
322. Findings in the Area of COVID-19 Reported from Zagazig University Hospital (Can Igg Antibodies Directed Against Different Targets Solve the Problem of False-positive Results In Sars-cov-2 Serology?)
323. Reports Outline COVID-19 Study Results from Boston University (Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection Associates With Unstable Housing and Occurs In the Presence of Antibodies)
324. Reports Summarize Biosensors Findings from University of Washington (Thermodynamically Coupled Biosensors for Detecting Neutralizing Antibodies Against Sars-cov-2 Variants)
325. Studies in the Area of Bordetella pertussis Reported from University of Texas (Antibodies Binding Diverse Pertactin Epitopes Protect Mice From Bordetella Pertussis Infection)
326. Research Conducted at Johns Hopkins University Has Provided New Information about HIV/AIDS (Tcr-mimic Bispecific Antibodies To Target the Hiv-1 Reservoir)
327. Report Summarizes COVID-19 Study Findings from Department of Internal Medicine (Flipped Inflammatory Time and the Role of Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2: Optimizing Tocilizumab Against Coronavirus Disease 2019)
328. Centers for Disease Control and Prevention Reports Findings in COVID-19 [Serologic Testing of Us Blood Donations To Identify Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-cov-2)-reactive Antibodies: December 2019-january 2020]
329. Reports from University of Leipzig Add New Data to Findings in COVID-19 (Antibody Course and Memory B-cell Response In the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection)
330. Investigators at Seoul National University Describe Findings in COVID-19 (Persistent Antibody Responses Up To 18 Months After Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection)
331. Study Results from Westlake University Provide New Insights into Biosensors (Rapid Biosensing Sars-cov-2 Antibodies In Vaccinated Healthy Donors)
332. Researchers from Capital Medical University Describe Findings in Dengue Hemorrhagic Fever (Seroepidemiologic Study On Convalescent Sera From Dengue Fever Patients In Jinghong, Yunnan)
333. New siRNA-Based Therapy Findings from Nanjing University Outlined (A Photoresponsive Antibody-sirna Conjugate for Activatable Immunogene Therapy of Cancer)
334. Findings from Ministry of Health Broaden Understanding of COVID-19 (Hybrid Proteins With Short Conformational Epitopes of the Receptor-binding Domain of Sars-cov-2 Spike Protein Promote Production of Virus-neutralizing Antibodies When Used for ...)
335. Hema-Quebec Details Findings in COVID-19 (Seroprevalence of Sars-cov-2 Antibodies Among Blood Donors In Quebec: an Update From a Serial Cross-sectional Study)
336. New Findings on COVID-19 from University of Texas San Antonio Summarized (Isotyping and Quantitation of the Humoral Immune Response To Sars-cov-2)
337. Findings on U.S. Military Research Reported by Investigators at U.S. Military HIV Research Program (Hiv-1 Infections With Multiple Founders Associate With the Development of Neutralization Breadth)
338. New Findings on COVID-19 Described by Investigators at University Hospital Heidelberg (Microscopy-based Assay for Semi-quantitative Detection of Sars-cov-2 Specific Antibodies In Human Sera a Semi-quantitative, High Throughput, Microscopy-based ...)
339. New COVID-19 Findings Has Been Reported by Investigators at Saint Luc University Clinic (Clinical Usefulness of Fully Automated Chemiluminescent Immunoassay for Quantitative Antibody Measurements In Covid-19 Patients)
340. Reports on Liver Cancer Findings from University of Missouri Provide New Insights (Nanoliposome C6-ceramide In Combination With Anti-ctla4 Antibody Improves Anti-tumor Immunity In Hepatocellular Cancer)
341. New COVID-19 Findings from Mayo Clinic Described (Low Antispike Antibody Levels Correlate With Poor Outcomes In Covid-19 Breakthrough Hospitalizations)
342. Study suggests COVID-19 Omicron variant infection induces limited immune response
343. COVID-19 booster essential, even among individuals previously infected
344. Researchers from University of Texas Southwestern Medical Center Dallas Detail New Studies and Findings in the Area of Hepatitis C Virus (Hepatitis C Epidemiology In a Large Urban Jail: a Changing Demographic)
345. New HIV/AIDS Findings from University of California San Francisco (UCSF) Outlined (First-in-human Immunopet Imaging of Hiv-1 Infection Using Zr-89-labeled Vrc01 Broadly Neutralizing Antibody)
346. Recent Findings in COVID-19 Described by Researchers from Sungkyunkwan University (Clinical Application of Rapid Diagnostic Test Kit for Sars-cov-2 Antibodies Into the Field of Patient Care)
347. New COVID-19 Study Findings Have Been Reported from Donald and Barbara Zucker School of Medicine at Hofstra Northwell (Passive Transfer of Sars-cov-2 Antibodies With Platelet Transfusions)
348. Findings in COVID-19 Reported from University of Regensburg (A Highly Specific and Sensitive Serological Assay Detects Sars-cov-2 Antibody Levels In Covid-19 Patients That Correlate With Neutralization)
349. Findings from University Clinical Hospital Mostar in the Area of COVID-19 Described (Sustained Seroprevalence of Sars-cov-2 Antibodies 1 Year After Infection: One of the First Covid-19 Cluster Cases In Bosnia and Herzegovina)
350. Showa University Reports Findings in Lung Diseases and Conditions (Anti-mda-5 Antibody-positive Clinically Amyopathic Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Treated With Therapeutic Plasma Exchange: a Case Series)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.